RxDoctor Payments Data

Amy Franklin, PA

Physician Assistant · Battle Creek, MINPI 1659048494

Payments from drug & device makers

$412in general payments, 2019–2025

Across 19 payments — averaging $21.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Guard Medical Inc.$100
  • Novo Nordisk$67
  • Amgen$45
  • Lilly USA, LLC$45
  • Xeris Pharmaceuticals, Inc.$40
  • AbbVie$29
  • plus $87 from 5 others

What the payments were for

  • Consulting fees$10024%
  • Food & beverage$31276%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$412 in reported general payments places this provider in the 60th percentile of 5,453 physician assistant providers in Michigan.

See all physician assistant providers in Michigan

Medicare billing

Part B allowed, 2024
$31,945
Medicare patients
184
Services billed
752

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter69$51,031
EliquisApixaban66$47,948
OzempicSemaglutide30$42,114
MounjaroTirzepatide36$38,294
TrulicityDulaglutide28$37,906
XareltoRivaroxaban23$26,790
JardianceEmpagliflozin13$20,535
RybelsusSemaglutide14$20,331
Tresiba Flextouch U-200Insulin Degludec19$11,418
SymbicortBudesonide/Formoterol Fumarate17$5,904
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen220$3,941
Levothyroxine Sodium204$3,767
Atorvastatin Calcium257$3,586
Omeprazole145$3,040
Albuterol Sulfate HfaAlbuterol Sulfate81$2,778

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$45$76,20064 claims
Novo NordiskOzempic, Rybelsus$67$62,44544 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 5,453 physician assistant providers in Michigan.

Other physician assistant in Battle Creek

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →